IDH1 and neoplasm: Patients less than 40 years of age with a tumor size less than 4 cm with an IDH mutation and 1p/19q co-deletion are considered low risk with a favorable prognosis overall and they are usually observed closely without the need of an immediate surgical intervention [6,7].